Drs. Teng and Verburg contributed equally to this work.
Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation
Article first published online: 28 JUL 2005
Copyright © 2005 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 52, Issue 8, pages 2272–2276, August 2005
How to Cite
Teng, Y. K. O., Verburg, R. J., Sont, J. K., Van Den Hout, W. B., Breedveld, F. C. and Van Laar, J. M. (2005), Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis & Rheumatism, 52: 2272–2276. doi: 10.1002/art.21219
- Issue published online: 28 JUL 2005
- Article first published online: 28 JUL 2005
- Manuscript Accepted: 9 MAY 2005
- Manuscript Received: 3 FEB 2005
- Dutch Arthritis Association. Grant Number: NR 99-1-301
- 6High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 2001; 44: 754–60., , , , , , et al.
- 9Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34–40., , , , , .
- 12The Dutch Arthritis Impact Measurement Scales (DUTCH-AIMS): assessment of physical and psychosocial aspects of health in rheumatoid arthritis]. Gedrag Gezondheid 1989; 17: 69–74.In Dutch., , , , . [